My Companies
Notification
Account
Log Out
Login
US FDA GMP-inspected Morpeth, UK facility Sept 3-11, 2026; issued Form-483 with 7 observations on practices, procedures and documentation. Company preparing detailed response within stipulated timeline.
Piramal Pharma Recreates Pledge Over 98.4 Million Shares
Piramal Pharma Reports Release Of 7.39% Share Pledge
Piramal Pharma Exercises Call Option For 41% Yapan Stake
Piramal Pharma Secures US FDA EIR For Sellersville Facility